AbstractUnrelated umbilical cord blood (UCB) transplantation has recently been explored in an increasing number of adult patients. The relative ease of procurement and the lower-than-anticipated risk of severe acute graft-versus-host disease has made UCB transplantation an appealing alternative to bone marrow-derived hematopoietic stem cells. The use of reduced-intensity or nonmyeloablative preparative regimens to allow engraftment of UCB broadens the scope of patients who may benefit from allogeneic immunotherapy, including elderly and medically infirm patients with no matched sibling donor. This review summarizes the available data on the use of UCB as an alternative source of hematopoietic stem cell transplantation in adult patients
AbstractWe report the outcome of 13 patients with advanced malignancies who underwent nonmyeloablati...
BACKGROUND: Promising results of cord-blood transplants from unrelated donors have been reported in ...
The aim of our study was to evaluate, through the Eurocord and European Group for Blood and Marrow T...
AbstractUnrelated umbilical cord blood (UCB) transplantation has recently been explored in an increa...
AbstractSince January 1996, we have administered myeloablative therapy followed by infusion of unrel...
AbstractUmbilical cord blood (UBC) stem cells are a useful stem cell source for patients without mat...
The Cord Blood Transplantation study group conducted a prospective study of unrelated cord blood tra...
Clinical studies focused on outcomes of umbilical cord blood transplantation (UCBT) for patients wit...
Allogeneic haematopoietic stem cell transplantation represents a potential life-saving procedure for...
AbstractLow incidence of graft-versus-host disease provides the major rational for pursuing umbilica...
AbstractThe lower morbidity and mortality of reduced-intensity conditioning (RIC) regimens have allo...
AbstractAlthough used mainly for transplantation of hematopoietic stem cells in the treatment of blo...
Umbilical cord blood transplantation (UCBT) is becoming a salvage treatment in lieu of bone marrow o...
AbstractUmbilical cord blood hematopoietic stem cells coming from related or unrelated donors are an...
AbstractAlthough allogeneic hematopoietic stem cell transplantation is a potentially curative approa...
AbstractWe report the outcome of 13 patients with advanced malignancies who underwent nonmyeloablati...
BACKGROUND: Promising results of cord-blood transplants from unrelated donors have been reported in ...
The aim of our study was to evaluate, through the Eurocord and European Group for Blood and Marrow T...
AbstractUnrelated umbilical cord blood (UCB) transplantation has recently been explored in an increa...
AbstractSince January 1996, we have administered myeloablative therapy followed by infusion of unrel...
AbstractUmbilical cord blood (UBC) stem cells are a useful stem cell source for patients without mat...
The Cord Blood Transplantation study group conducted a prospective study of unrelated cord blood tra...
Clinical studies focused on outcomes of umbilical cord blood transplantation (UCBT) for patients wit...
Allogeneic haematopoietic stem cell transplantation represents a potential life-saving procedure for...
AbstractLow incidence of graft-versus-host disease provides the major rational for pursuing umbilica...
AbstractThe lower morbidity and mortality of reduced-intensity conditioning (RIC) regimens have allo...
AbstractAlthough used mainly for transplantation of hematopoietic stem cells in the treatment of blo...
Umbilical cord blood transplantation (UCBT) is becoming a salvage treatment in lieu of bone marrow o...
AbstractUmbilical cord blood hematopoietic stem cells coming from related or unrelated donors are an...
AbstractAlthough allogeneic hematopoietic stem cell transplantation is a potentially curative approa...
AbstractWe report the outcome of 13 patients with advanced malignancies who underwent nonmyeloablati...
BACKGROUND: Promising results of cord-blood transplants from unrelated donors have been reported in ...
The aim of our study was to evaluate, through the Eurocord and European Group for Blood and Marrow T...